The newly established Clatterbridge Cancer Centre Biobank is just
one part of a multi-million pound project to transform cancer care
in Merseyside and Cheshire, UK. The biobank will act as a major
resource for academic oncologists and help further build links
between The Clatterbridge Cancer Centre, Liverpool University
and key research partners. Matrix Gemini has a proven track
record with other biobanks in the city and with the Liverpool GCLP
facility which collects, stores and analyses samples from clinical
trials.
- Full compliance with all regulatory guidelines such as HTA, GCLP, MHRA, FDA 21 CFR Part 11
- Full management of sample collection & registration, sample shipments, storage, sample picking/shipping and disposal
- Complete location recording e.g. freezer, shelf, container and container position
- Project completed within the NHS Trust budget
- Biological samples enable research into the molecular mechanisms of cancer
- Configuration tools allow easy future system extensions
- Comprehensive audit trail capabilities ensure complete chain-of-custody
The recording and auditing of every action associated with the samples is critical to our requirements
The CCC Biobank has been established to provide biological samples linked to patient outcome data to facilitate good quality research into the molecular mechanisms of cancer. The samples will be supplied by CCC patients diagnosed with cancer (following full informed consent) as well as by ‘healthy volunteers’ who have not been diagnosed with cancer in order to provide age-matched controls.
Download to continue reading...
